Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder
Open accessThe DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Abstract
There is evidence for both similarity and distinction in the presentation and molecular characterization of schizophrenia and bipolar disorder. In this study, we characterized protein abnormalities in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder using two-dimensional gel electrophoresis. Tissue samples were obtained from 35 individuals with schizophrenia, 35 with bipolar disorder and 35 controls. Eleven protein spots in schizophrenia and 48 in bipolar disorder were found to be differentially expressed (P<0.01) in comparison to controls, with 7 additional spots found to be altered in both diseases. Using mass spectrometry, 15 schizophrenia-associated proteins and 51 bipolar disorder-associated proteins were identified. The functional groups most affected included synaptic proteins (7 of the 15) in schizophrenia and metabolic or mitochondrial-associated proteins (25 of the 51) in bipolar disorder. Six of seven synaptic-associated proteins abnormally expressed in bipolar disorder were isoforms of the septin family, while two septin protein spots were also significantly differentially expressed in schizophrenia. This finding represented the largest number of abnormalities from one protein family. All septin protein spots were upregulated in disease in comparison to controls. This study provides further characterization of the synaptic pathology present in schizophrenia and of the metabolic dysfunction observed in bipolar disorder. In addition, our study has provided strong evidence implicating the septin protein family of proteins in psychiatric disorders for the first time.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Proteomic analysis of SZ DLPFC samples identified 15 differentially expressed proteins, 7 of which were synaptic 164.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [164]
Citations
Cites
High resolution two-dimensional electrophoresis of proteins.
O'Farrell, P. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41496-8 · Cited by 19,246 · cited 1×
“5 ml Eppendorf tubes with 1 ml of solubilization buffer, a lysis buffer based on that originally used by O’Farrell”
MethodCorrelation between Protein and mRNA Abundance in Yeast
Gygi, S. P., Rochon, Y., Franza, B. R., & Aebersold, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1720 · Cited by 3,819
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
The dynamin superfamily: universal membrane tubulation and fission molecules?
Praefcke, G. J. K., & McMahon, H. T. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1313 · Cited by 1,377 · cited 1×
“0055) and is localized to presynaptic nerve terminals in the brain”
BackgroundPantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., Yung, A. R., Bullmore, E. T., Brewer, W., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,310
A comparison of selected mRNA and protein abundances in human liver
Anderson, L., & Seilhamer, J. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150180333 · Cited by 1,262 · cited 1×
“27 However, mRNA may not be the most reliable method to use in order to gain insight into the underlying pathophysiology of schizophrenia, where abnormalities in gene function may or may not affect downstream protein expression”
MethodProteomic analysis of NMDA receptor–adhesion protein signaling complexes
Husi, H., Ward, M. A., Choudhary, J. S., Blackstock, W. P., & Grant, S. G. N. (2000) · Nature Neuroscience · doi:10.1038/76615 · Cited by 1,194
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
High rates of schizophrenia in adults with velo-cardio-facial syndrome
Murphy, K. C., Jones, L. A., & Owen, M. J. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.940 · Cited by 1,024 · cited 1×
“2, parts of which are deleted in velo–cardio–facial syndrome and whose sufferers have been found to have a much higher rate of schizophrenia than the general population (30p)”
BackgroundPrabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 971 · cited 4×
“In support of our findings are those of Prabakaran et al. (2004), who found that DYN-I and II were increased in the grey matter but decreased in the white matter of schizophrenics in comparison to controls, while a recent proteomics study of the anterior cingulate cortex in schizophrenia also…”
BackgroundResultInfluentialThe Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
Goff, D. C., & Coyle, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1367 · Cited by 915 · cited 1×
“69 Postsynaptic density and glutamatergic system implicated by findings Several proteins that were differentially expressed in this investigation, namely PACSIN, NF-L, DYN-I and septin 5, are involved in the function of the pre- andsor postsynaptic density, and through these in NMDA-regulated glutamatergic neurotransm…”
BackgroundMirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)00085-4 · Cited by 882
Yan, J. X., Wait, R., Berkelman, T., Harry, R. A., Westbrook, J. A., Wheeler, C. H., & Dunn, M. J. (2000) · Electrophoresis · doi:10.1002/1522-2683(200011)21:17<3666::aid-elps3666>3.0.co;2-6 · Cited by 707 · cited 1×
“For preparative gels, the PlusOne Silver Staining kit (Amersham Biosciences, Uppsala, Sweden) was used with modifications to allow subsequent use with mass spectrometric analysis”
MethodSelf-citationFunctional and Anatomical Aspects of Prefrontal Pathology in Schizophrenia
Goldman-Rakic, P. S., & Selemon, L. D. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.3.437 · Cited by 668 · cited 1×
“1 Support for dysfunction in this brain region at the imaging, cellular and molecular level in schizophreni”
BackgroundNeuroimaging studies of mood disorder effects on the brain
Sheline, Y. I. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00347-0 · Cited by 660
Cotter, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.386 · Cited by 634 · cited 1×
“15 with similar reductions in neuronal size observed in BPD”
BackgroundSelf-citationRajkowska, G., Selemon, L. D., & Goldman-Rakic, P. S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.3.215 · Cited by 537
Johnston-Wilson, N. L., Sims, C. D., Hofmann, J.-P., Anderson, L., Shore, A. D., Torrey, E. F., Yolken, R. H., & the Stanley Neuropathology Consortium (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000696 · Cited by 531
Iwamoto, K., Bundo, M., & Kato, T. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi022 · Cited by 495 · cited 1×
“In addition to this, and in support of our data, in a sub-group of medication-free bipolar disorder patients, mitochondrial gene transcripts were shown to be increased in expression in comparison with controls”
ResultNeurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains
Torrey, E. F., Barci, B. M., Webster, M. J., Bartko, J. J., Meador-Woodruff, J. H., & Knable, M. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.019 · Cited by 426 · cited 1×
“17 In a review of 100 neurochemical markers assessed in multiple brain areas in the Stanley Foundation Brain Consortium, it was found that developmentalssynaptic, GABAergic and markers involved in signal transduction were all reduced in the schizophrenia group in the prefrontal cortex”
BackgroundSelemon, L. D., Rajkowska, G., & Goldman-Rakic, P. S. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980316)392:3<402::aid-cne9>3.0.co;2-5 · Cited by 393 · cited 1×
“Cytoarchitectural studies have found evidence for an increase in neuronal density”
BackgroundMitochondrial dysfunction in bipolar disorder
Kato, T., & Kato, N. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020305.x · Cited by 380 · cited 1×
“31 The finding of abnormal metabolic-associated proteins supports previous work suggesting a ‘mitochondrial hypothesis’ of the disorde”
ResultThe septin CDCrel-1 binds syntaxin and inhibits exocytosis
Beites, C. L., Xie, H., Bowser, R., & Trimble, W. S. (1999) · Nature Neuroscience · doi:10.1038/8100 · Cited by 377
Cortical Abnormalities in Schizophrenia Identified by Structural Magnetic Resonance Imaging
Goldstein, J. M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.6.537 · Cited by 369
Rabilloud, T., Valette, C., & Lawrence, J. J. (1994) · ELECTROPHORESIS · doi:10.1002/elps.11501501223 · Cited by 366 · cited 1×
“2p wsv Pharmalyte, pH 3–10) and a protein load of 100 μg for analytical gels and 400 μg for preparative gels was loaded onto the strips using in-gel rehydration”
MethodThe role of the prefrontal cortex in higher cognitive functions
Frith, C., & Dolan, R. (1996) · Cognitive Brain Research · doi:10.1016/s0926-6410(96)00054-7 · Cited by 343 · cited 1×
“dtd"[ ]> Introduction The dorsolateral prefrontal cortex (dlPFC) (Brodmann areas 9, 10, 42, 45 and 46) has primary functions in working memory, willed action and decision making”
Glatt, S. J., Everall, I. P., Kremen, W. S., Corbeil, J., Šášik, R., Khanlou, N., Han, M., Liew, C.-C., & Tsuang, M. T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507666102 · Cited by 322
Improved and simplified in‐gel sample application using reswelling of dry immobilized pH gradients
Sanchez, J., Rouge, V., Pisteur, M., Ravier, F., Tonella, L., Moosmayer, M., Wilkins, M. R., & Hochstrasser, D. F. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150180305 · Cited by 303
Sanfilipo, M., Lafargue, T., Rusinek, H., Arena, L., Loneragan, C., Lautin, A., Feiner, D., Rotrosen, J., & Wolkin, A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.471 · Cited by 281
Vawter, M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00377-2 · Cited by 275
Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder
Zarate, C. A., Singh, J., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.021 · Cited by 274 · cited 1×
“57 These findings thus support evidence for glutamatergic dysfunction in mood disorder”
BackgroundEastwood, S. L., & Harrison, P. J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00530-5 · Cited by 263
Beasley, C. L., Pennington, K., Behan, A., Wait, R., Dunn, M. J., & Cotter, D. (2006) · PROTEOMICS · doi:10.1002/pmic.200500069 · Cited by 263
Self-citationLi, J. Z., Vawter, M. P., Walsh, D. M., Tomita, H., Evans, S. J., Choudary, P. V., Lopez, J. F., Avelar, A., Shokoohi, V., Chung, T., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh065 · Cited by 261
Pierri, J. N., Volk, C. L. E., Auh, S., Sampson, A., & Lewis, D. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.466 · Cited by 257
Pathology of Layer V Pyramidal Neurons in the Prefrontal Cortex of Patients With Schizophrenia
Black, J. E., Kodish, I. M., Grossman, A. W., Klintsova, A. Y., Orlovskaya, D., Vostrikov, V., Uranova, N., & Greenough, W. T. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.742 · Cited by 250
Application of cDNA microarrays to examine gene expression differences in schizophrenia
Vawter, M. P., Barrett, T., Cheadle, C., Sokolov, B. P., Wood, W. H., Donovan, D. M., Webster, M., Freed, W. J., & Becker, K. G. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00522-6 · Cited by 244
Kolluri, N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1200 · Cited by 241
Ryan, M. M., Lockstone, H. E., Huffaker, S. J., Wayland, M. T., Webster, M. J., & Bahn, S. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001875 · Cited by 238
Dynamin GTPase regulated by protein kinase C phosphorylation in nerve terminals
Robinson, P. J., Sontag, J.-M., Liu, J.-P., Fykse, E. M., Slaughter, C., McMahontt, H., & Südhof, T. C. (1993) · Nature · doi:10.1038/365163a0 · Cited by 235 · cited 1×
“62 DYN-I is a GTPase essential for the recovery of synaptic vesicles from the neuronal membrane once the contents have been release”
BackgroundBroadbelt, K. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00201-3 · Cited by 229
Sun, X., Wang, J.-F., Tseng, M., & Young, L. T. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0623 · Cited by 228
Maurer, I., Zierz, S., & Möller, H.-J. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00075-x · Cited by 221
Kristiansen, L. V., Beneyto, M., Haroutunian, V, & Meador-Woodruff, J. H. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001844 · Cited by 220
Kremer, B. E., Haystead, T., & Macara, I. G. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-03-0267 · Cited by 208 · cited 1×
“Functionally, septins are GTP-binding proteins often found in association with actin and microtubule filaments, and decreased septin expression has been found to lead to increased microtubule stability”
BackgroundIdentification of Septins in Neurofibrillary Tangles in Alzheimer's Disease
Kinoshita, A., Kinoshita, M., Akiyama, H., Tomimoto, H., Akiguchi, I., Kumar, S., Noda, M., & Kimura, J. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65743-4 · Cited by 203 · cited 1×
“74 Septins 2 and 4 have previously been associated with Alzheimer's disease due to their localization in neurofibrillary tangle”
BackgroundHerbert, B. R., & Righetti, P. G. (2000) · Electrophoresis · doi:10.1002/1522-2683(200011)21:17<3851::aid-elps3851>3.0.co;2-q · Cited by 203
Self-citationAll three PACSIN isoforms bind to endocytic proteins and inhibit endocytosis
Modregger, J., Ritter, B., Witter, B., Paulsson, M., & Plomann, M. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.24.4511 · Cited by 202
Expression profiling the human septin gene family
Hall, P. A., Jung, K., Hillan, K. J., & Russell, S. H. (2005) · The Journal of Pathology · doi:10.1002/path.1789 · Cited by 195 · cited 1×
“While the functional roles of the septin family of proteins within the brain are unclear at present, there is a growing literature indicating that they have important, diverse and developmental stage-specific functions within the brain”
BackgroundVolumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder?
Strakowski, S. M., Adler, C. M., & DelBello, M. P. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01160.x · Cited by 189
Vawter, M. P., Tomita, H., Meng, F., Bolstad, B., Li, J., Evans, S., Choudary, P., Atz, M., Shao, L., Neal, C., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001830 · Cited by 188
Thomson, P. A., Wray, N. R., Millar, J. K., Evans, K. L., Hellard, S. L., Condie, A., Muir, W. J., Blackwood, D. H. R., & Porteous, D. J. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001669 · Cited by 187
Sokolov, B. P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062454.x · Cited by 185 · cited 1×
“Cytoarchitectural studies have found evidence for an increase in neuronal density,(9) decrease in neuronal size,(10,11) reduced pyramidal neuron dendritic field(12,13) and decreased dendritic spine density(14,15) with similar reductions in neuronal size observed in BPD.(16) Efforts to determine the neurochemical and m…”
BackgroundWebster, M. J., Knable, M. B., Johnston-Wilson, N., Nagata, K., Inagaki, M., & Yolken, R. H. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0646 · Cited by 179 · cited 1×
“30 More specifically, reduced levels of phosphorylated GFAP have been reported in the PFC and hippocampus”
BackgroundDifferential expression and regulation of multiple dynamins.
Sontag, J. M., Fykse, E. M., Ushkaryov, Y., Liu, J. P., Robinson, P. J., & Südhof, T. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41812-6 · Cited by 175
Hennah, W., Tuulio‐Henriksson, A., Paunio, T., Ekelund, J., Varilo, T., Partonen, T., Cannon, T. D., Lönnqvist, J. K., & Peltonen, L. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001731 · Cited by 174 · cited 1×
“67 and which also interacts with the disrupted in schizophrenia 1 protein strongly implicated in the disease”
BackgroundEastwood, S. L., & Harrison, P. J. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000741 · Cited by 170
Toro, C. T., & Deakin, J. F. W. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.003 · Cited by 169
The Synaptic Hypothesis of Schizophrenia
Frankle, W. G., Lerma, J., & Laruelle, M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00423-9 · Cited by 166
A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia
Clark, D., Dedova, I. V., Cordwell, S. J., & Matsumoto, I. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001806 · Cited by 160
Inagaki, M., Gonda, Y., Nishizawa, K., Kitamura, S., Sato, C., Ando, S., Tanabe, K., Kikuchi, K., Tsuiki, S., & Nishi, Y. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39622-x · Cited by 155
Postmortem Changes in the Level of Brain Proteins
Fountoulakis, M., Hardmeier, R., Höger, H., & Lübec, G. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7529 · Cited by 150 · cited 1×
“35 Given these findings, and those of others that have found significant alterations at the protein level with varying PMI times”
BackgroundSEPT5_v2 is a parkin-binding protein
Choi, P., Snyder, H. M., Petrucelli, L., Theisler, C. M., Chong, M., Zhang, Y., Lim, K., Chung, K. K. K., Kehoe, K. J., D'adamio, L., et al. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00318-8 · Cited by 148 · cited 1×
“83 and septin 5 is a known binding partner of the Parkinson's disease-associated protein parkin”
BackgroundFatemi, S. H., Earle, J. A., Stary, J. M., Lee, S., & Sedgewick, J. (2001) · Neuroreport · doi:10.1097/00001756-200110290-00023 · Cited by 144 · cited 1×
“58 closely related to SNAP-25, proteins which have been previously implicated in the pathogenesis of schizophrenia”
BackgroundByk, T., Dobránsky, T., Cifuentes-Díaz, C., & Sobel, A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-02-00688.1996 · Cited by 140
Knable, M. B., Torrey, Ε. F., Webster, M. J., & Bartko, J. J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00521-4 · Cited by 135 · cited 1×
“16 Efforts to determine the neurochemical and molecular basis for these cellular alterations have revealed abnormalities in neurotransmission, signal transduction, inhibitory interneuron function and glial cells”
BackgroundSNAP-25 reduction in the hippocampus of patients with schizophrenia
Thompson, P. M., Egbufoama, S., & Vawter, M. P. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00027-7 · Cited by 135
Regional Cerebral Glucose Metabolic Abnormalities in Bipolar II Depression
Mah, L., Zarate, C. A., Singh, J. B., Duan, Y.-F., Luckenbaugh, D. A., Manji, H. K., & Drevets, W. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.009 · Cited by 132 · cited 1×
“89 and also previous imaging studies which have found an increased metabolism, for example”
BackgroundDifferential localization of septins in the mouse brain
Kinoshita, A., Noda, M., & Kinoshita, M. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001211)428:2<223::aid-cne3>3.0.co;2-m · Cited by 116 · cited 1×
“80 Septin 5 (also known as CDCrel-1 and Peanut-like 1) appears particularly interesting as it has been previously found to colocalize with GABAergic vesicles”
BackgroundHippocampal Complexin Proteins and Cognitive Dysfunction in Schizophrenia
Sawada, K., Barr, A. M., Nakamura, M., Arima, K., Young, C. E., Dwork, A. J., Falkai, P., Phillips, A. G., & Honer, W. G. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.263 · Cited by 114
An online database for brain disease research
Higgs, B. W., Elashoff, M., Richman, S., & Barci, B. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-70 · Cited by 113
Reductions in cholesterol and synaptic markers in association cortex in mood disorders
Beasley, C. L., Honer, W. G., von Bergmann, K., Falkai, P., Lütjohann, D., & Bayer, T. A. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00239.x · Cited by 112
Self-citationThe septin Sept5/CDCrel-1 competes with α-SNAP for binding to the SNARE complex
Beites, C. L., CAMPBELL, K. A., & Trimble, W. S. (2005) · Biochemical Journal · doi:10.1042/bj20041090 · Cited by 111
Toro, C. T., Hallak, J. E. C., Dunham, J. S., & Deakin, J. F. W. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.05.067 · Cited by 105 · cited 1×
“30 However, an increased protein expression of GFAP in lamina II, III, IV and VI in BA9 of the dlPFC has also been reported”
BackgroundA mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress
Marchbanks, R. M., Ryan, M., Day, I. N. M., Owen, M., McGuffin, P., & Whatley, S. A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00011-2 · Cited by 101
Intersectin Regulates Fission and Internalization of Caveolae in Endothelial Cells
Predescu, S. A., Predescu, D. N., Timblin, B. K., Stan, R. V., & Malik, A. B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-01-0041 · Cited by 100
Mitochondrial Function is Differentially Altered in the Basal Ganglia of Chronic Schizophrenics
Prince, J. A., Blennow, K., Gottfries, C. G., Karlsson, I., & Oreland, L. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00016-0 · Cited by 99
Görg, A., Postel, W., Günther, S., Weser, J., Strahler, J. R., Hanash, S., Somerlot, L., & Kuick, R. D. (1988) · Electrophoresis · doi:10.1002/elps.1150090108 · Cited by 99
The genetics of schizophrenia: glutamate not dopamine?
Collier, D. A., & Li, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.105 · Cited by 99
Bezchlibnyk, Y. B., Wang, J., McQueen, G. M., & Young, L. T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00628.x · Cited by 96
Whatley, S. A., Curti, D., Gupta, F. D., Ferrier, I. N., Jones, S., Taylor, C., & Marchbanks, R. M. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000375 · Cited by 92
Eastwood, S. L., Burnet, P. W. J., & Harrison, P. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.029 · Cited by 84
Altered Expression of 14-3-3 Genes in the Prefrontal Cortex of Subjects with Schizophrenia
Middleton, F. A., Peng, L., Lewis, D. A., Levitt, P. R., & Mirnics, K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300674 · Cited by 82
14-3-3 protein ? chain gene (YWHAH) polymorphism and its genetic association with schizophrenia
Toyooka, K., Muratake, T., Tanaka, T., Igarashi, S., Watanabe, H., Takeuchi, H., Hayashi, S., Maeda, M., Takahashi, M., Tsuji, S., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990416)88:2<164::aid-ajmg13>3.0.co;2-3 · Cited by 70
Schizophrenia: a genetic disorder of the synapse?
Owen, M. J., O'Donovan, M. C., & Harrison, P. J. (2005) · BMJ · doi:10.1136/bmj.330.7484.158 · Cited by 67
Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder
Saito, T., Guan, F., Papolos, D. F., Lau, S., Klein, M., Fann, C. S. J., & Lachman, H. M. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000871 · Cited by 65
Molecular characterization of deletion breakpoints in adults with 22q11 deletion syndrome
Weksberg, R., Stachon, A. C., Squire, J. A., Moldovan, L., Bayani, J., Meyn, M. S., Chow, E. W. C., & Bassett, A. S. (2006) · Human Genetics · doi:10.1007/s00439-006-0242-x · Cited by 63 · cited 1×
“75 A recent molecular examination of the deletion breakpoints in adults with 22q11 deletion syndrome found that the septin 5 gene is located within the region deleted in all the patients suffering this disorder, including all those with schizophrenia ( n e44 in total)”
BackgroundFranzén, B., Yang, Y., Sunnemark, D., Wickman, M., Ottervald, J., Oppermann, M., & Sandberg, K. (2003) · PROTEOMICS · doi:10.1002/pmic.200300535 · Cited by 59
Kowara, R., Chen, Q., Milliken, M., & Chakravarthy, B. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03383.x · Cited by 57 · cited 1×
“53 DRP-3 is also involved in glutamatergic function, and a degraded form of the protein occurs in the presence of glutamate excitotoxicity ( N -methyl- D -aspartate (NMDA)) and oxidative stress”
BackgroundCorre, S. L., Harper, C. G., López-García, P., Ward, P. B., & Catts, S. V. (2000) · Neuroreport · doi:10.1097/00001756-200004070-00017 · Cited by 55
Localization of a novel septin protein, hCDCrel-1, in neurons of human brain
Caltagarone, J., Rhodes, J. L., Honer, W. G., & Bowser, R. P. (1998) · Neuroreport · doi:10.1097/00001756-199808240-00042 · Cited by 50 · cited 1×
“81 In a study investigating the distribution of septin 5 in the adult human brain, differential centrifugation revealed it to associate predominantly with neurons and to co-purify with SNAP-25 and synaptophysin marked synaptosomes”
BackgroundSt�ber, G., Hebebrand, J., Cichon, S., Br�ss, M., B�nisch, H., Lehmkuhl, G., Poustka, F., Schmidt, M., Remschmidt, H., Propping, P., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990416)88:2<158::aid-ajmg12>3.0.co;2-w · Cited by 47
Mitochondrial related gene expression changes are sensitive to agonal-pH state
Vawter, M. P., Tomita, H., Meng, F., Bolstad, B. M., Li, J., Evans, S. J., Choudary, P. V., Atz, M. E., Shao, L., Neal, C. R., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001850 · Cited by 46
Tunbridge, E. M., Weinberger, D. R., & Harrison, P. J. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001767 · Cited by 46 · cited 1×
“Of interest in this regard is a recent study that describes an increase in the proportion of one form of catechol O -methyltransferase in comparison with total catechol O -methyltransferase protein expression, the gene for which is also located on 22q11, in schizophrenia and bipolar disorder compared to control”
BackgroundHoriuchi, M., Loebrich, S., Brandstaetter, J. H., Kneussel, M., & Betz, H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03198.x · Cited by 20
Rosoklija, G., Toomayan, G., Ellis, S. P., Keilp, J., Mann, J. J., Latov, N., Hays, A. P., & Dwork, A. J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.349 · Cited by 1
Research works printed but not linked: 4
- Eastwood SL, Burnet PW, Harrison PJ . Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia. Biol Psychiatry 2005; 57: 702–710. · DOI
- Sawada K, Barr AM, Nakamura M, Arima K, Young CE, Dwork AJ et al. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry 2005; 62: 263–272. · DOI · Paper page
- Owen MJ, O’Donovan MC, Harrison PJ . Schizophrenia: a genetic disorder of the synapse? BMJ 2005; 330: 158–159. · DOI · Paper page
- Frankle WG, Lerma J, Laruelle M . The synaptic hypothesis of schizophrenia. Neuron 2003; 39: 205–216. · DOI · Paper page
Cited by
Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
Savitz, J., & Drevets, W. C. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.01.004 · Cited by 494
Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
Clay, H. B., Daws, S., & Konradi, C. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.08.007 · Cited by 399
“…et al., 2005; Karry et al., 2004; Klushnik et al., 1991; Konradi et al., 2004; MacDonald et al., 2006; Middleton et al., 2002; Mill et al., 2008; Pennington et al., 2008; Washizuka et al., 2005, 2009), and linkage analysis showed an association of both disorders with genes involved in…”
BackgroundThe dietary pattern of patients with schizophrenia: A systematic review
Dipasquale, S., Pariante, C. M., Dazzan, P., Aguglia, E., McGuire, P., & Mondelli, V. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.005 · Cited by 394
“…is particularly harmful in patients with schizophrenia, who show an elevated oxidative stress (Minutolo et al., 2012), high levels of pro-inflammatory cytokines and several metabolic abnormalities, also at the onset of the illness (Mondelli et al., 2011; Pennington et al., 2008; Ryan et al., 2003).”
BackgroundSelf-citationPrefrontal Cortical Dendritic Spine Pathology in Schizophrenia and Bipolar Disorder
Konopaske, G. T., Lange, N., Coyle, J. T., & Benes, F. M. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1582 · Cited by 379
Neurofilaments: neurobiological foundations for biomarker applications
Gafson, A. R., Barthélemy, N. R., Bomont, P., Carare, R. O., Durham, H. D., Julien, J.-P., Kuhle, J., Leppert, D., Nixon, R. A., Weller, R. O., et al. (2020) · Brain · doi:10.1093/brain/awaa098 · Cited by 325
Metadata
- Authors
- Pennington, K., Beasley, C. L., Dicker, P., Fagan, A., English, J., Pariante, C. M., Wait, R., Dunn, M. J., & Cotter, D. R.
- Affiliations
- Royal College of Surgeons in Ireland (IE)
- University of British Columbia (CA)
- University College Dublin (IE)
- King's College London (GB)
- Imperial College London (GB)
- Corresponding author
- Cotter, D R
- Venue
- Molecular Psychiatry
- Published
- 2007-10-16
- Volume
- 13
- Issue
- 12
- Pages
- 1102-1117
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2084002557
- Cited by
- 227
- References
- 95
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 9 · 2022: 13 · 2021: 10 · 2020: 10 · 2019: 8 · 2018: 7 · 2017: 14 · 2016: 19 · 2015: 21 · 2014: 20 · 2013: 14 · 2012: 11
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Lincoln Repository (University of Lincoln) (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, bipolar disorder, dorsolateral prefrontal cortex, synaptic proteins, mitochondrial proteins, metabolic dysfunction, differentially expressed proteins, mental illness
- MeSH terms
- Adult, Analysis of Variance, Bipolar Disorder, Chromatography, Liquid, Female, Humans, Male, Middle Aged, Schizophrenia, Electrophoresis, Gel, Two-Dimensional, Case-Control Studies, Databases, Factual, Prefrontal Cortex, Proteomics, Intracellular Signaling Peptides and Proteins, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.